Medpace Holdings, Inc. Reports Third Quarter 2026 Results
Business Wire•21/10/2026•16:15 ET
0
Key Highlights
- ➤Q3 revenue $716.0 million, up 8.5% year over year
- ➤Q3 GAAP diluted EPS $4.84, versus $3.86 prior year
- ➤Q3 net new business awards $873.4 million, up 10.6%
- ➤2026 revenue guidance $2.835 billion-$2.855 billion, growth of 12.0%-12.8%
- ➤New $1.0 billion share repurchase authorization runs through December 31, 2028
* Revenue of $716.0 million in the third quarter of 2026 increased 8.5% from revenue of $659.9 million for the comparable prior-year period, representing a backlog conversion rate of 23.8%.
* Net new business awards were $873.4 million in the third quarter of 2026, representing an increase of 10.6% from net new business awards of $789.6 million for the comparable prior-year period.
Get started
Create a free account to read the full story.